# PTSD Screening Tool Comparison

This reference helps clinicians choose between PC-PTSD-5 and PCL-5 based on clinical context, time constraints, and assessment goals.

## Quick Comparison Table

| Feature | PC-PTSD-5 | PCL-5 |
|---------|-----------|-------|
| **Purpose** | Brief screen | Comprehensive assessment |
| **Items** | 5 | 20 |
| **Time** | 1-2 minutes | 5-10 minutes |
| **Response Format** | Binary (Yes/No) | 0-4 Likert scale |
| **Score Range** | 0-5 | 0-80 |
| **Cutoff** | ≥3 | ≥33 (provisional PTSD) |
| **Sensitivity** | 93% | Varies by cutoff |
| **Specificity** | 85% | Varies by cutoff |
| **DSM-5 Alignment** | Simplified criteria | Full DSM-5 criteria |
| **Can Diagnose PTSD** | No (screen only) | Provisional (interview needed) |
| **Tracks Severity** | No | Yes |
| **Monitors Treatment** | Limited | Yes |
| **Best Setting** | Primary care, triage | Mental health specialty |

## When to Use PC-PTSD-5

### Ideal Scenarios
1. **Primary Care Settings**
   - Quick triage in busy medical settings
   - Annual wellness visits
   - Initial trauma screening
   - Time-limited appointments

2. **Population Screening**
   - Large-scale screening programs
   - Emergency department triage
   - Military/veteran health screenings
   - Community mental health outreach

3. **Initial Assessment**
   - First contact with patient
   - Determining need for further assessment
   - Ruling out PTSD in low-risk populations
   - Pre-referral screening

4. **Limited Resources**
   - Settings with minimal mental health training
   - When full assessment not immediately available
   - Telehealth initial screenings
   - Non-specialist providers

### Advantages
- Very brief administration time
- Easy to score and interpret
- Low burden on patient
- Can be self-administered
- Minimal training required
- High sensitivity (captures most PTSD cases)
- Binary format simple for patients with cognitive impairment

### Limitations
- **Cannot diagnose PTSD** (screening tool only)
- No severity measurement
- Limited treatment monitoring capability
- No symptom cluster breakdown
- Positive screen requires follow-up with PCL-5
- Less useful for tracking treatment progress
- May miss subthreshold cases that still warrant treatment

### Follow-Up Requirements
**If PC-PTSD-5 ≥3:**
- **Must administer PCL-5** for comprehensive assessment
- Clinical interview to confirm diagnosis
- Do not diagnose PTSD based on PC-PTSD-5 alone

**If PC-PTSD-5 0-2:**
- Routine monitoring
- Reassess if clinical presentation changes
- Consider PCL-5 if strong clinical suspicion despite negative screen

## When to Use PCL-5

### Ideal Scenarios
1. **Mental Health Specialty Settings**
   - Outpatient mental health clinics
   - PTSD specialty clinics
   - Trauma treatment programs
   - Psychiatric practices

2. **Comprehensive Assessment**
   - After positive PC-PTSD-5 screen
   - Diagnostic clarification needed
   - Symptom severity measurement required
   - Treatment planning

3. **Treatment Monitoring**
   - Baseline before starting trauma treatment
   - Progress monitoring during treatment
   - Measuring treatment response
   - Tracking symptom changes over time

4. **Research and Program Evaluation**
   - Clinical trials
   - Program outcome measurement
   - Quality improvement initiatives
   - Detailed symptom tracking

### Advantages
- Comprehensive symptom assessment
- Tracks severity (0-80 scale)
- Aligns with DSM-5 diagnostic criteria
- Provides symptom cluster scores
- Sensitive to treatment changes
- Can identify dominant symptom patterns
- Useful for treatment planning
- Provisional diagnostic capability

### Limitations
- Longer administration time (5-10 minutes)
- More burden on patient
- Requires more clinician time for interpretation
- May be overwhelming in acute crisis
- Not ideal for quick triage
- Requires literacy or assistance for completion

### Interpretation Requirements
- Review all four symptom clusters
- Check DSM-5 diagnostic criteria met
- Consider total severity score
- Identify dominant symptom patterns for treatment targeting
- Clinical interview still needed for formal diagnosis

## Clinical Decision Flowchart

```
Patient with known/suspected trauma exposure
         |
         v
Time-limited setting OR initial screening?
         |
    YES  |  NO
         |
    PC-PTSD-5
         |
    Score ≥3?  →  NO  →  Monitor, reassess if needed
         |
        YES
         |
    PCL-5 (full assessment)
         |
    Interpret severity and clusters
         |
    Clinical interview
         |
    Diagnosis and treatment plan
```

## Combined Use Strategy

### Two-Stage Screening (Recommended for Primary Care)
1. **Stage 1:** Administer PC-PTSD-5 to all patients with trauma exposure
2. **Stage 2:** If PC-PTSD-5 ≥3, administer PCL-5 for comprehensive assessment

**Advantages:**
- Efficient use of time
- Reduces burden on negative screens
- Ensures positive screens get thorough evaluation
- Cost-effective screening approach

### PCL-5 Only (Recommended for Specialty Settings)
Skip PC-PTSD-5 and administer PCL-5 directly when:
- Patient already in mental health treatment
- Strong clinical suspicion of PTSD
- Treatment monitoring needed
- Detailed symptom profile required
- Time permits comprehensive assessment

## Special Populations

### Military/Veteran Populations
- **PC-PTSD-5:** Excellent for VA primary care settings
- **PCL-5:** Standard in VA mental health specialty care
- Consider using both in two-stage approach

### Primary Care Medical Patients
- **PC-PTSD-5:** Ideal for routine screening
- **PCL-5:** Only if PC-PTSD-5 positive or high clinical suspicion

### Emergency/Crisis Settings
- **PC-PTSD-5:** Quick triage tool
- **PCL-5:** Defer until patient stabilized
- Focus on immediate safety, not comprehensive PTSD assessment

### Trauma Therapy Patients
- **PC-PTSD-5:** Not sufficient for treatment monitoring
- **PCL-5:** Recommended at:
  - Baseline (before treatment)
  - Mid-treatment (progress check)
  - Post-treatment (outcome measurement)
  - Follow-up (relapse monitoring)

### Research Settings
- **PC-PTSD-5:** Pre-screening for study eligibility
- **PCL-5:** Primary outcome measure in trials
- Both may be used in epidemiological studies

## Treatment Monitoring Recommendations

### PC-PTSD-5 for Monitoring
**Not recommended as primary treatment monitoring tool**
- Too brief to capture nuanced symptom changes
- Binary format insensitive to improvement
- Cannot track symptom cluster changes

**May be useful for:**
- Quick check-ins between comprehensive assessments
- Confirming sustained symptom reduction
- Large-scale program evaluation (screening in/out)

### PCL-5 for Monitoring
**Recommended frequency:**
- Baseline (before treatment start)
- Every 4-8 weeks during active treatment
- Post-treatment
- 3-month and 6-month follow-up

**Interpreting change:**
- 5-10 points: Reliable change
- 10-20 points: Clinically significant improvement
- >20 points: Substantial improvement

For detailed treatment response interpretation, see [severity-levels.md](severity-levels.md)

## Common Clinical Questions

### "Can I skip PC-PTSD-5 and just use PCL-5?"
**Yes**, if:
- You have time for comprehensive assessment
- Patient is in mental health specialty setting
- You need detailed symptom information
- You'll use results for treatment planning

**No**, if:
- Time is very limited (busy primary care)
- You're screening large populations
- You need quick triage tool
- Patient unlikely to tolerate longer assessment

### "My patient scored 2 on PC-PTSD-5 but I'm still concerned. Should I give PCL-5?"
**Yes**. PC-PTSD-5 is a screening tool. Clinical judgment overrides screening results. Administer PCL-5 if:
- Strong clinical suspicion despite negative screen
- Patient reports distress not captured by screener
- Trauma history particularly severe
- Functional impairment evident

### "Patient scored 40 on PCL-5 but doesn't meet all DSM-5 cluster criteria. Do they have PTSD?"
Use clinical judgment. PCL-5 provides *provisional* diagnosis. Consider:
- Symptom severity (40 = moderate-severe range)
- Functional impairment
- Clinical interview findings
- May be subthreshold PTSD still warranting treatment

### "How often should I readminister these tools?"
**PC-PTSD-5:**
- Annually in primary care (if trauma history)
- When clinical presentation changes
- After new trauma exposure

**PCL-5:**
- Baseline before trauma treatment
- Every 4-8 weeks during active treatment
- Post-treatment and follow-up
- When symptoms worsen

## Psychometric Properties

### PCL-5 Validation Data

**Structure:**
- 20 items mapping directly to DSM-5 PTSD diagnostic criteria
- Four symptom clusters:
  - Intrusion (re-experiencing)
  - Avoidance
  - Negative alterations in cognitions and mood
  - Alterations in arousal and reactivity

**Diagnostic Accuracy:**
- **Recommended cutoff:** 31-33 for provisional PTSD diagnosis
- Cutoff varies by population and clinical setting

**Treatment Monitoring:**
- **Reliable change:** 5-10 point change
- **Clinically significant improvement:** 10-12 point change
- **Return to healthy range:** Score <28 may indicate recovery
- Sensitive to treatment effects in trauma-focused therapy

**Interpretation:**
- Total score reflects overall PTSD symptom severity
- Subscale scores identify dominant symptom patterns
- Useful for targeting treatment interventions

### PC-PTSD-5 Validation Data

**Diagnostic Accuracy:**
- **Sensitivity:** 93% (excellent at detecting PTSD cases)
- **Specificity:** 85% (good at ruling out PTSD)
- **Recommended cutoff:** ≥3 positive responses

**Gender Considerations:**
- Cutoff of 3-4 may vary by gender and population
- Some studies suggest different optimal cutoffs
- Clinical judgment should guide interpretation

## Summary Recommendations

**Use PC-PTSD-5 when:**
- Quick screening needed (1-2 minutes)
- Primary care or general medical setting
- Initial triage or population screening
- Limited mental health resources
- Determining need for further assessment

**Use PCL-5 when:**
- Comprehensive assessment needed
- After positive PC-PTSD-5 screen
- Mental health specialty setting
- Treatment planning or monitoring
- Detailed symptom profile required
- Measuring treatment outcomes

**Use both (two-stage) when:**
- Primary care setting with referral capability
- Efficient screening protocol desired
- Large population to screen
- Resources permit follow-up on positive screens

**Always remember:**
- PC-PTSD-5 cannot diagnose PTSD (93% sensitivity, 85% specificity)
- PCL-5 provides provisional diagnosis only
- Clinical interview required for formal diagnosis
- Safety assessment needed regardless of tool used
- Trauma-informed approach essential for all trauma screening
- Treatment monitoring: 10-12 point PCL-5 change = clinically significant improvement

For trauma-informed assessment techniques, see [trauma-informed-approach.md](trauma-informed-approach.md)
